Artículos de revistas sobre el tema "Tumour environment"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Tumour environment".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Bennaceur, Karim, Jessica Chapman, Leila Brikci-Nigassa, Kamel Sanhadji, Jean-louis Touraine y Jacques Portoukalian. "Dendritic cells dysfunction in tumour environment". Cancer Letters 272, n.º 2 (diciembre de 2008): 186–96. http://dx.doi.org/10.1016/j.canlet.2008.05.017.
Texto completoShahriyari, Leili. "Cell dynamics in tumour environment after treatments". Journal of The Royal Society Interface 14, n.º 127 (febrero de 2017): 20160977. http://dx.doi.org/10.1098/rsif.2016.0977.
Texto completoSinha, Sweta, Paramjeet Singh y Mehmet Emir Koksal. "Mathematical and Numerical Modelling of Interference of Immune Cells in the Tumour Environment". Discrete Dynamics in Nature and Society 2023 (3 de enero de 2023): 1–18. http://dx.doi.org/10.1155/2023/9006678.
Texto completoSchumacher, Neele, Stefan Rose-John y Dirk Schmidt-Arras. "ADAM-Mediated Signalling Pathways in Gastrointestinal Cancer Formation". International Journal of Molecular Sciences 21, n.º 14 (20 de julio de 2020): 5133. http://dx.doi.org/10.3390/ijms21145133.
Texto completoInácio Pinto, Nelson, June Carnier, Lila M. Oyama, Jose Pinhata Otoch, Paulo Sergio Alcântara, Flavio Tokeshi y Claudia M. Nascimento. "Cancer as a Proinflammatory Environment: Metastasis and Cachexia". Mediators of Inflammation 2015 (2015): 1–13. http://dx.doi.org/10.1155/2015/791060.
Texto completoDavid, E., F. Blanchard, M. F. Heymann, G. De Pinieux, F. Gouin, F. Rédini y D. Heymann. "The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets". Sarcoma 2011 (2011): 1–8. http://dx.doi.org/10.1155/2011/932451.
Texto completoOnion, D., R. Argent, R. Kumari, S. Watson, A. Axel y B. Hall. "158 3D tumour models for the assessment of tumour micro-environment targeted therapies". European Journal of Cancer Supplements 8, n.º 7 (noviembre de 2010): 55. http://dx.doi.org/10.1016/s1359-6349(10)71863-2.
Texto completoDomagala-Kulawik, J. y M. Maskey-Warzecowska. "T-regulatory cells in COPD or tumour environment". European Respiratory Journal 34, n.º 1 (30 de junio de 2009): 284. http://dx.doi.org/10.1183/09031936.00025609.
Texto completoLi, L., I. Spendlove, J. Morgan y L. G. Durrant. "CD55 is over-expressed in the tumour environment". British Journal of Cancer 84, n.º 1 (2001): 80–86. http://dx.doi.org/10.1054/bjoc.2000.1570.
Texto completovan Tienderen, Groot Koerkamp, IJzermans, van der Laan y Verstegen. "Recreating Tumour Complexity in a Dish: Organoid Models to Study Liver Cancer Cells and their Extracellular Environment". Cancers 11, n.º 11 (1 de noviembre de 2019): 1706. http://dx.doi.org/10.3390/cancers11111706.
Texto completoOushy, Soliman, Justin E. Hellwinkel, Mary Wang, Ger J. Nguyen, Dicle Gunaydin, Tessa A. Harland, Thomas J. Anchordoquy y Michael W. Graner. "Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype". Philosophical Transactions of the Royal Society B: Biological Sciences 373, n.º 1737 (20 de noviembre de 2017): 20160477. http://dx.doi.org/10.1098/rstb.2016.0477.
Texto completoYatagai, Nanae, Takumi Hasegawa, Rika Amano, Izumi Saito, Satomi Arimoto, Daisuke Takeda, Yasumasa Kakei y Masaya Akashi. "Transcutaneous Carbon Dioxide Decreases Immunosuppressive Factors in Squamous Cell Carcinoma In Vivo". BioMed Research International 2021 (2 de julio de 2021): 1–9. http://dx.doi.org/10.1155/2021/5568428.
Texto completoGoggi, Julian L., Boominathan Ramasamy, Yun Xuan Tan, Siddesh V. Hartimath, Jun Rong Tang, Peter Cheng, Rasha Msallam, Ann-Marie Chacko, You Yi Hwang y Edward G. Robins. "Granzyme B PET Imaging Stratifies Immune Checkpoint Inhibitor Response in Hepatocellular Carcinoma". Molecular Imaging 2021 (9 de diciembre de 2021): 1–8. http://dx.doi.org/10.1155/2021/9305277.
Texto completoJunttila, Melissa R. y Frederic J. de Sauvage. "Influence of tumour micro-environment heterogeneity on therapeutic response". Nature 501, n.º 7467 (septiembre de 2013): 346–54. http://dx.doi.org/10.1038/nature12626.
Texto completoKUBITZA, MARION, LUCAS HICKEY y GREGORY ROBERTS. "Influence of host microvascular environment on tumour vascular endothelium". International Journal of Experimental Pathology 80, n.º 1 (25 de diciembre de 2001): 01–10. http://dx.doi.org/10.1046/j.1365-2613.1999.00100.x.
Texto completoAl-Rayahi, Izzat A. M., Lee R. Machado y Cordula M. Stover. "Properdin Is a Modulator of Tumour Immunity in a Syngeneic Mouse Melanoma Model". Medicina 57, n.º 2 (21 de enero de 2021): 85. http://dx.doi.org/10.3390/medicina57020085.
Texto completoFRAGOYIANNIS, GEORGE, FOTEINI KARIOTOU y PANAYIOTIS VAFEAS. "On the avascular ellipsoidal tumour growth model within a nutritive environment". European Journal of Applied Mathematics 31, n.º 1 (18 de septiembre de 2018): 111–42. http://dx.doi.org/10.1017/s0956792518000499.
Texto completoVyth-Dreese, Florry y Arjan Griffioen. "Angiostasis as a way to improve immunotherapy". Thrombosis and Haemostasis 101, n.º 06 (2009): 1025–31. http://dx.doi.org/10.1160/th08-08-0552.
Texto completoCai, Yan, Jie Wu, Shixiong Xu y Zhiyong Li. "A Hybrid Cellular Automata Model of Multicellular Tumour Spheroid Growth in Hypoxic Microenvironment". Journal of Applied Mathematics 2013 (2013): 1–10. http://dx.doi.org/10.1155/2013/519895.
Texto completoWhite, Lydia G., Hannah E. Goy, Alinor J. Rose y Alexander D. McLellan. "Controlling Cell Trafficking: Addressing Failures in CAR T and NK Cell Therapy of Solid Tumours". Cancers 14, n.º 4 (15 de febrero de 2022): 978. http://dx.doi.org/10.3390/cancers14040978.
Texto completoCiccocioppo, Fausta, Paola Lanuti, Marco Marchisio y Sebastiano Miscia. "Extracellular Vesicles Involvement in the Modulation of the Glioblastoma Environment". Journal of Oncology 2020 (28 de enero de 2020): 1–8. http://dx.doi.org/10.1155/2020/3961735.
Texto completoZou, Weiping. "Immunosuppressive networks in the tumour environment and their therapeutic relevance". Nature Reviews Cancer 5, n.º 4 (18 de marzo de 2005): 263–74. http://dx.doi.org/10.1038/nrc1586.
Texto completoStratford, I. J., G. E. Adams, J. C. M. Bremner, S. Cole, H. S. Edwards, N. Robertson y P. J. Wood. "Manipulation and Exploitation of the Tumour Environment for Therapeutic Benefit". International Journal of Radiation Biology 65, n.º 1 (enero de 1994): 85–94. http://dx.doi.org/10.1080/09553009414550121.
Texto completoBrown, M. "757 Hypoxic tumour environment and its implication for cancer treatment". European Journal of Cancer Supplements 1, n.º 5 (septiembre de 2003): S227. http://dx.doi.org/10.1016/s1359-6349(03)90783-x.
Texto completoSantiago, Alina, Wolfgang Eicheler, Jan Bussink, Paul Rijken, Ala Yaromina, Bettina Beuthien-Baumann, Albert J. van der Kogel, Michael Baumann y Mechthild Krause. "Effect of cetuximab and fractionated irradiation on tumour micro-environment". Radiotherapy and Oncology 97, n.º 2 (noviembre de 2010): 322–29. http://dx.doi.org/10.1016/j.radonc.2010.07.007.
Texto completoMueller-Klieser, W. "SP-0173 CLINICAL RELEVANCE OF TUMOUR MICRO-ENVIRONMENT AND METABOLISM". Radiotherapy and Oncology 103 (mayo de 2012): S66—S67. http://dx.doi.org/10.1016/s0167-8140(12)70512-1.
Texto completoAlarcón, T., H. M. Byrne y P. K. Maini. "A cellular automaton model for tumour growth in inhomogeneous environment". Journal of Theoretical Biology 225, n.º 2 (noviembre de 2003): 257–74. http://dx.doi.org/10.1016/s0022-5193(03)00244-3.
Texto completoFreeman, Patrick y Ainhoa Mielgo. "Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities". Cancers 12, n.º 9 (21 de septiembre de 2020): 2687. http://dx.doi.org/10.3390/cancers12092687.
Texto completoGrimes, David Robert y Frederick J. Currell. "Oxygen diffusion in ellipsoidal tumour spheroids". Journal of The Royal Society Interface 15, n.º 145 (agosto de 2018): 20180256. http://dx.doi.org/10.1098/rsif.2018.0256.
Texto completoKawiak, Jerzy, Grazyna Hoser y Joanna Domagała-Kulawik. "Problems of Cancer Treatment. Part I. Theory of Treatment Based on Known Mechanisms of Anticancer Immunological Responses". Advances in Cell Biology 5, n.º 1 (1 de marzo de 2017): 72–95. http://dx.doi.org/10.1515/acb-2017-0006.
Texto completoKissová, Viktória, Zuzana Ševčíková, Viera Revajová, Róbert Herich y Mikuláš Levkut. "Mast cells and eosinophils in rat mammary gland tumours induced by N-Nitroso-N-methylurea". Bulletin of the Veterinary Institute in Pulawy 59, n.º 3 (1 de septiembre de 2015): 411–16. http://dx.doi.org/10.1515/bvip-2015-0060.
Texto completoGrimshaw, M. J. "Endothelins and hypoxia-inducible factor in cancer". Endocrine-Related Cancer 14, n.º 2 (junio de 2007): 233–44. http://dx.doi.org/10.1677/erc-07-0057.
Texto completoFlavell, Richard A., Shomyseh Sanjabi, Stephen H. Wrzesinski y Paula Licona-Limón. "The polarization of immune cells in the tumour environment by TGFβ". Nature Reviews Immunology 10, n.º 8 (9 de julio de 2010): 554–67. http://dx.doi.org/10.1038/nri2808.
Texto completoKunz, Robert F., Byron J. Gaskin, Qunhua Li, Sam Davanloo-Tajbakhsh y Cheng Dong. "Multi-scale biological and physical modelling of the tumour micro-environment". Drug Discovery Today: Disease Models 16 (2015): 7–15. http://dx.doi.org/10.1016/j.ddmod.2015.03.001.
Texto completoCross, N. A., M. Papageorgiou y C. L. Eaton. "Bone marrow stromal cells promote growth and survival of prostate cancer cells". Biochemical Society Transactions 35, n.º 4 (20 de julio de 2007): 698–700. http://dx.doi.org/10.1042/bst0350698.
Texto completoApte, Ron N., Yakov Krelin, Xiaoping Song, Shahar Dotan, Eli Recih, Moshe Elkabets, Yaron Carmi et al. "Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis, tumour invasiveness and tumour–host interactions". European Journal of Cancer 42, n.º 6 (abril de 2006): 751–59. http://dx.doi.org/10.1016/j.ejca.2006.01.010.
Texto completoKapoor, Simran S. y Dietmar M. W. Zaiss. "Emerging Role of EGFR Mutations in Creating an Immune Suppressive Tumour Microenvironment". Biomedicines 10, n.º 1 (27 de diciembre de 2021): 52. http://dx.doi.org/10.3390/biomedicines10010052.
Texto completoSchmidt-Arras, Dirk, Eithan Galun y Stefan Rose-John. "The two facets of gp130 signalling in liver tumorigenesis". Seminars in Immunopathology 43, n.º 4 (28 de mayo de 2021): 609–24. http://dx.doi.org/10.1007/s00281-021-00861-0.
Texto completoSas-Chen, Aldema, Swati Srivastava y Yosef Yarden. "The short and the long: non-coding RNAs and growth factors in cancer progression". Biochemical Society Transactions 45, n.º 1 (8 de febrero de 2017): 51–64. http://dx.doi.org/10.1042/bst20160131.
Texto completoCostello, P. C., D. MacDonald, W. McDonald, R. Hammond, V. Sloby, B. Faubert y J. Megyesi. "Determination of human brain tumour therapy response using an ex vivo invasion assay provides a potential step toward individualized treatment". Journal of Clinical Oncology 24, n.º 18_suppl (20 de junio de 2006): 11509. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.11509.
Texto completoLee, Hyunah. "Combination Therapy of Cancer – Escalating the Effect of Dendritic Cell-based Cancer Vaccine in the Tumour Micro-environment". European Oncology & Haematology 08, n.º 04 (2012): 261. http://dx.doi.org/10.17925/eoh.2012.08.4.261.
Texto completoBabourina-Brooks, Ben, Martin Wilson, Theodoros N. Arvanitis, Andrew C. Peet y Nigel P. Davies. "MRS water resonance frequency in childhood brain tumours: a novel potential biomarker of temperature and tumour environment". NMR in Biomedicine 27, n.º 10 (14 de agosto de 2014): 1222–29. http://dx.doi.org/10.1002/nbm.3177.
Texto completoKariotou, Foteini y Panayiotis Vafeas. "The Avascular Tumour Growth in the Presence of Inhomogeneous Physical Parameters Imposed from a Finite Spherical Nutritive Environment". International Journal of Differential Equations 2012 (2012): 1–25. http://dx.doi.org/10.1155/2012/175434.
Texto completoPeyrode, Caroline, François Gouin, Aurélien Vidal, Philippe Auzeloux, Sophie Besse, Marie-Mélanie Dauplat, Serge Askienazy et al. "A “Proteoglycan Targeting Strategy” for the Scintigraphic Imaging and Monitoring of the Swarm Rat Chondrosarcoma Orthotopic Model". Sarcoma 2011 (2011): 1–8. http://dx.doi.org/10.1155/2011/691608.
Texto completoIafrate, M., T. Prayer Galetti, V. Bronte, F. Pagano, G. Gri, T. Kasic y A. Viola. "155 Tumour infiltrating lymphocytes (TIL) in prostatic neoplasia of untreated patients are inhibited in their function by tumour environment". European Urology Supplements 3, n.º 2 (febrero de 2004): 41. http://dx.doi.org/10.1016/s1569-9056(04)90156-x.
Texto completoColtrini, Daniela, Roberto Ronca, Mirella Belleri, Luciano Zardi, Stefano Indraccolo, Valentina Scarlato, Raffaella Giavazzi y Marco Presta. "Impact of VEGF-dependent tumour micro-environment on EDB fibronectin expression by subcutaneous human tumour xenografts in nude mice". Journal of Pathology 219, n.º 4 (diciembre de 2009): 455–62. http://dx.doi.org/10.1002/path.2626.
Texto completoOosterwijk, E. y R. J. Gillies. "Targeting ion transport in cancer". Philosophical Transactions of the Royal Society B: Biological Sciences 369, n.º 1638 (19 de marzo de 2014): 20130107. http://dx.doi.org/10.1098/rstb.2013.0107.
Texto completoWirta, Erkki-Ville, Säde Szeto, Ulrika Hänninen, Maarit Ahtiainen, Jan Böhm, Jukka-Pekka Mecklin, Lauri A. Aaltonen y Toni T. Seppälä. "Prognostic Value of Immune Environment Analysis in Small Bowel Adenocarcinomas with Verified Mutational Landscape and Predisposing Conditions". Cancers 12, n.º 8 (23 de julio de 2020): 2018. http://dx.doi.org/10.3390/cancers12082018.
Texto completoCarbone, Michele, Sarah T. Arron, Bruce Beutler, Angela Bononi, Webster Cavenee, James E. Cleaver, Carlo M. Croce et al. "Tumour predisposition and cancer syndromes as models to study gene–environment interactions". Nature Reviews Cancer 20, n.º 9 (29 de mayo de 2020): 533–49. http://dx.doi.org/10.1038/s41568-020-0265-y.
Texto completoMorgan, J., I. Spendlove y L. G. Durrant. "The role of CD55 in protecting the tumour environment from complement attack". Tissue Antigens 60, n.º 3 (septiembre de 2002): 213–23. http://dx.doi.org/10.1034/j.1399-0039.2002.600303.x.
Texto completo